Elevated IL-15 concentrations in the sarcoidosis lung are independent of granuloma burden and disease phenotypes

Abstract

Sarcoidosis is a systemic granulomatous disease predominantly affecting the lungs. The mechanisms promoting disease pathogenesis and progression are unknown, although interleukin-15 (IL-15) has been associated with the immune-mediated inflammation of sarcoidosis. Because the identification of a mechanistically based, clinically relevant biomarker for sarcoidosis remains elusive, we hypothesized this role for IL-15. Pulmonary sarcoidosis granuloma formation was modeled using trehalose 6,6′-dimicolate (TDM), which was administered into wild-type and three lineages of mice: those overexpressing IL-15, deficient in IL-15, and deficient in IL-15 receptor α. The number of granulomas per lung was counted and normalized to the wild type. IL-15 concentrations were measured in the bronchoalveolar lavage (BAL) from healthy controls and subjects with sarcoidosis in our cohort, where associations between IL-15 levels and clinical manifestations were sought. Findings were validated in another independent sarcoidosis cohort. TDM administration resulted in similar granuloma numbers across all lineages of mice. IL-15 concentrations were elevated in the BAL of both human cohorts, irrespective of disease phenotypes. In exploratory analysis, an association with obesity was observed, and various other soluble mediators were identified in the BAL of both cohorts. Although IL-15 is enriched in the sarcoidosis lung, it was independent of disease pathogenesis or clinical manifestations in our mouse model and human cohorts of sarcoidosis. An association with obesity perhaps reflects the ongoing inflammatory processes of these comorbid conditions. Our findings showed that IL-15 is redundant for disease pathogenesis and clinical progression of sarcoidosis.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 01, 2021
Source ID
10.1152/ajplung.00575.2020

Entities

People

  • Angela Liu
  • Carrighan Perry
  • Changwan Ryu
  • Charles S Dela Cruz
  • Erica L Herzog
  • Genta Ishikawa
  • Lokesh Sharma
  • Maksym Minasyan
  • Mridu Gulati
  • Naftali Kaminski
  • Santos Bermejo
  • Taylor Adams
  • Taylor Pivarnik
  • Wei Liu
  • Xiaohua Peng

Organizations

  • National Heart, Lung, and Blood Institute
  • United States Department of Defense
  • United States Department of Veterans Affairs
  • Yale University

Tags

Fields of Study

  • Medicine

Readers

  • Immunology
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Oncology (Cancer Research).